8-KItem 5.02 · Officer/Director ChangeItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements
On Mar 9, 2026 Quest Diagnostics ($DGX) added Timothy Wentworth, former CEO of Walgreens Boots Alliance,…
Filed with the SEC on · Summarized by InvestorsBot
On Mar 9, 2026 Quest Diagnostics ($DGX) added Timothy Wentworth, former CEO of Walgreens Boots Alliance, to its Board. He was appointed to the Compensation & Leadership Development and Quality & Compliance Committees. 👔🧪 #QuestDiagnostics #BoardUpdate
The Board deemed Wentworth independent under NYSE standards. He’ll be compensated as a non‑employee director and received a prorated one‑time restricted stock unit grant valued at ≈ $43,000 upon joining. 🏛️📈 $DGX #CorporateGovernance #Healthcare